TCI Wealth Advisors’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-422
Closed -$4K 2385
2021
Q4
$4K Buy
+422
New +$4.48K ﹤0.01% 1868
2020
Q3
Sell
-100
Closed 1623
2020
Q2
$0 Buy
+100
New +$361 ﹤0.01% 1616
2019
Q4
Sell
-98
Closed -$1K 1648
2019
Q3
$1K Buy
+98
New +$545 ﹤0.01% 1351

Other funds holding ORGO

TCI Wealth Advisors's ORGO Position: Q1 2022 in Review

TCI Wealth Advisors sold out of Organogenesis Holdings (ORGO) in Q1 2022, closing a stake of 422 shares — an estimated $4K sold.

TCI Wealth Advisors first reported a position in ORGO in Q3 2019 and held it in 3 quarters. The position peaked at $4K in Q4 2021. 156 funds tracked by Wall St. Rank hold ORGO as of Q1 2022.

  • TCI Wealth Advisors reported no remaining Organogenesis Holdings position as of Q1 2022 after selling out during the quarter.
  • TCI Wealth Advisors sold 422 Organogenesis Holdings shares in Q1 2022, an estimated $4K.
  • TCI Wealth Advisors first reported a position in Organogenesis Holdings in Q3 2019 and held it in 3 quarters.
  • TCI Wealth Advisors's Organogenesis Holdings position peaked at $4K in Q4 2021.
  • 156 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2022.

Based on TCI Wealth Advisors's 13F filing for Q1 2022, filed 29 Apr 2022.